Work

Efficacy and Safety of Prescription Omega-3 Fatty Acids for the Prevention of Recurrent Symptomatic Atrial Fibrillation

Year: 2010

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: JAMA

DOI: 10.1001/jama.2010.1735

Authors: Peter R. Kowey, James A. Reiffel, Kenneth A. Ellenbogen, Gerald V. Naccarelli, Craig M. Pratt

Institutions: Main Line Health, Lankenau Institute for Medical Research, Columbia University Irving Medical Center, Virginia Commonwealth University Medical Center, Pennsylvania State University

Language: English

Topic: Atrial Fibrillation Management and Outcomes

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Bristol-Myers Squibb, Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, Gilead Sciences, Dartmouth College, Boston Scientific Corporation, Daiichi-Sankyo, Astellas Pharma, Biosense Webster

OpenAlex ID: W1968786896

FWCI: 23.51

Cites: 23

Cited by: 200

Related to: 10